Management of Fungal Infections Complicating Granulocytopenia
Invasive fungal infections are common complications reported with increasing frequency in granulocytopenic patients. These invasive mycoses cause substantial morbidity and mortality in patients receiving aggressive cytotoxic chemotherapy and ablative radiation therapy. The problem of invasive mycoses is further complicated by the appearance of new fungal pathogens and increasing reports of emerging resistance to established antifungal compounds. The two most common fungal groups infecting granulocytopenic patients are Candida species and Aspergillus species.
KeywordsFungal Infection Candida Species Invasive Aspergillosis Invasive Mycosis Aspergillus Species
Unable to display preview. Download preview PDF.
- 5.Rodu, B., Griffin, I., and Gockerman, J. Oral candidiasis in cancer patients. South Med J 77: 312–314, 1984.Google Scholar
- 8.Meunier, F., Gerain, J., Snoeck, R., et al. Fluconazole therapy of oropharyngeal candidiasis in cancer patients. In: Recent Trends in the Discovery, Development, and Evaluation of Antifungal Agents. R. Fromtling, Ed. R. J. Prous Science, Barcelona, Spain, 1988, pp. 169–174.Google Scholar
- 12.Aisner, J., Murillo, J., Schimpff, S. C., et al. Invasive aspergillosis in acute leukemia: Correlation with nose cultures and antibiotic use. Ann Intern Med 90: 4–9, 1979.Google Scholar
- 21.Walsh, T. J., and Pizzo, P. A. Treatment of systemic fungal infections: Recent progress and current problems. Eur J Clin Microbiol 7: 460–475, 1988.Google Scholar